The availability of continuous glucose data empowers individuals with DM to make informed decisions about their dietary choices, physical activity, and insulin dosing, fostering a proactive approach to managing their condition and improving their quality of life, eating patterns, motivation, and satisfaction with diabetic management compared to SMBG. The gene discussed is INS; the disease is diabetes mellitus.